In the context of this patient's overall health, which follow-up studies should his presenting symptom prompt?
First-line Treatment for "Diabetic Stomach"
Symptoms of diabetic gastroparesis include nausea, vomiting, early satiety, and bloating. Where should management start?
SGLT2 Inhibitors: Basic Training Quiz
The sodium glucose cotransporter-2 inhibitors are the newest diabetes drugs available. Have you got the basic concepts under your belt? Try these 6 questions and find out.
Danish Study Suggests Cardioprotective Effects of GLP-1 Agonist and Insulin
Evidence to date is conflicting on the potential role of antihyperglycemic drugs, old and new, in cardioprotection. Results reported here add to the pool and fuel ongoing study.
Why Not Prescribe a SGLT2 Inhibitor for This Patient?
The sodium glucose cotransporter-2 inhibitors have many advantages eg, modest A1c reduction and low hypoglycemia risk. But careful patient selection is critical.
Inside Insulin: 5 Sets of Facts, Figures, and Findings
Optimizing the use of insulin for treatment of hyperglycemia in patients with diabetes is an ongoing research endeavor. Here, several recent developments you should know about.
Widespread "Yellow Bumps"
A woman with poorly controlled type 2 diabetes presented with widespread “yellow bumps" of sudden onset. What's your diagnosis?
Why Is a “Medical Care Opportunity” a Waste of Time?
Those friendly reminders; you get them every day—Mrs X hasn’t refilled a scrip; Mr J needs an eye exam; Ms Q may be noncompliant with her ARB. Listen, I promise I DO know what the guidelines say!
By clicking Accept, you agree to become a member of the UBM Medica Community.